Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
|
journal
|
July 2016 |
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
|
journal
|
September 2009 |
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
|
journal
|
June 2018 |
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
|
journal
|
November 2018 |
Commonality despite exceptional diversity in the baseline human antibody repertoire
|
journal
|
January 2019 |
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
|
journal
|
January 2016 |
Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans
|
journal
|
December 2019 |
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function
|
journal
|
February 2013 |
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
|
journal
|
February 2021 |
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
|
journal
|
September 2018 |
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
|
journal
|
February 2000 |
Neutralization tiers of HIV-1
|
journal
|
January 2018 |
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
|
journal
|
May 2014 |
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers
|
journal
|
January 2019 |
Multiple roles for HIV broadly neutralizing antibodies
|
journal
|
October 2019 |
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
Isolation of a Monoclonal Antibody That Targets the Alpha-2 Helix of gp120 and Represents the Initial Autologous Neutralizing-Antibody Response in an HIV-1 Subtype C-Infected Individual
|
journal
|
May 2011 |
Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity
|
journal
|
December 2016 |
High frequency of shared clonotypes in human B cell receptor repertoires
|
journal
|
February 2019 |
The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following Immunization
|
journal
|
April 2019 |
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
|
journal
|
June 2018 |
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
|
journal
|
July 2010 |
Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved
|
journal
|
December 2014 |
PHENIX : building new software for automated crystallographic structure determination
|
journal
|
October 2002 |
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
|
journal
|
February 2018 |
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
|
journal
|
July 2019 |
What Are the Most Powerful Immunogen Design Vaccine Strategies?: Reverse Vaccinology 2.0 Shows Great Promise
|
journal
|
February 2017 |
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
|
journal
|
November 2009 |
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
|
journal
|
February 2017 |
Neutralizing antibodies to HIV-1 induced by immunization
|
journal
|
February 2013 |
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
Convergent Antibody Signatures in Human Dengue
|
journal
|
June 2013 |
Inhibition of Mammalian Glycan Biosynthesis Produces Non-self Antigens for a Broadly Neutralising, HIV-1 Specific Antibody
|
journal
|
September 2007 |
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
|
journal
|
December 2017 |
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
|
journal
|
April 2016 |
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
|
journal
|
September 2018 |
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
|
journal
|
May 2019 |
Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting
|
journal
|
September 2011 |
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
|
journal
|
October 2018 |
Public antibodies to malaria antigens generated by two LAIR1 insertion modalities
|
journal
|
August 2017 |
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
|
journal
|
May 2019 |
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
|
journal
|
August 2010 |
Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies
|
journal
|
October 2017 |
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
|
journal
|
August 2016 |
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
|
journal
|
May 2015 |
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies
|
journal
|
June 2015 |
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
|
journal
|
February 2018 |
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
|
journal
|
August 2010 |
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
|
journal
|
May 2012 |
Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1
|
journal
|
March 2005 |
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
|
journal
|
July 2014 |
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
|
journal
|
July 2019 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
|
journal
|
January 2016 |
Development of the primary antibody repertoire
|
journal
|
November 1987 |
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
|
journal
|
September 2006 |
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
|
journal
|
August 2011 |
Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility
|
journal
|
April 2008 |
The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection
|
journal
|
December 2007 |
IMGT®, the international ImMunoGeneTics information system® 25 years on
|
journal
|
November 2014 |
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine
|
journal
|
August 2010 |
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
|
journal
|
June 2017 |
Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops
|
journal
|
March 2012 |
Recurrent Variable Region Gene Usage and Somatic Mutation in the Human Antibody Response to the Capsular Polysaccharide of Streptococcus pneumoniae Type 23F
|
journal
|
August 2002 |
Somatic generation of antibody diversity
|
journal
|
April 1983 |
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
|
journal
|
April 2017 |
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
|
journal
|
May 2012 |
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors
|
journal
|
January 2013 |
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
|
journal
|
March 2016 |
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
|
journal
|
January 2014 |
Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity
|
journal
|
August 2004 |
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|
journal
|
August 2011 |
Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties
|
journal
|
January 2015 |
IMGT, the international ImMunoGeneTics database
|
journal
|
January 1999 |
Automated electron microscope tomography using robust prediction of specimen movements
|
journal
|
October 2005 |
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
|
journal
|
December 2004 |
Diversity Considerations in HIV-1 Vaccine Selection
|
journal
|
June 2002 |
An MPER antibody neutralizes HIV-1 using germline features shared among donors
|
journal
|
November 2019 |
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection
|
journal
|
February 2000 |